Overall, the market is seeing red today. The Dow Jones Industrial Average (Dow Jones Indices:.DJI) is down 36 points as of 11 a.m. EDT, with little momentum to push it higher.
Keep Reading →
May 13 - News
A study published in The New England Journal of Medicine testing omega-3 fatty acids -- commonly found in fish oil -- in patients with risk factors for cardiovascular disease ...
Keep Reading →
May 13 - News
With the SPDR S&P Biotech Index up 32% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Keep Reading →
May 13 - News
Editor's Note: Related tickers: Wal-Mart Stores, Inc. (NYSE:WMT), Tesco Corporation (USA) (NASDAQ:TESO), Goldman Sachs Group, Inc. (NYSE:GS), Virgin Media Inc.
Keep Reading →
May 13 - News
LONDON -- Dividend income accounts for around two-thirds of total returns, the actual rate of return taking into account both capital and income appreciation.
Keep Reading →
May 12 - News
The words of the great big-band leader Duke Ellington came to mind after hearing the first quarter results from Sarepta Therapeutics Inc (NASDAQ:SRPT) : "It don't mean a thing...
Keep Reading →
May 9 - News
Exchange-traded funds are all the rage these days, and for good reason.
Keep Reading →
May 8 - News
GlaxoSmithKline plc (ADR) (NYSE:GSK) is a pharmaceutical and healthcare company headquartered in the United Kingdom.
Keep Reading →
May 6 - News
The best thing about the stock market is that you can make money in either direction. Historically, stock indexes have tended to trend up over the long term.
Keep Reading →
May 6 - News
As I noted nine weeks ago, cancer statistics are both staggering and disappointing.
Keep Reading →
May 6 - News
Every Sunday I make it a point to examine a combination of earnings stories or Food and Drug Administration panel reviews or PDUFA decisions in the upcoming week that you can'...
Keep Reading →
May 5 - News
LONDON -- If you want to be eligible for a dividend payment, or if you're hoping a share price might drop disproportionately when the time has passed, you need to be aware of ...
Keep Reading →
May 4 - News
The market for prescription and over-the-counter drugs is huge and hugely profitable.
Keep Reading →
May 2 - News
As the market continues to climb, investors are beginning to see thinning dividend yields on many of their big pharma shares.
Keep Reading →
May 1 - Dividend Stocks, News
LONDON -- While crippling austerity in Europe and fiscal obstacles could put the brake on growth rates there, in developing regions a backdrop of accommodative central bank action...
Keep Reading →
May 1 - News
Dividend stocks can be a great addition to your portfolio, especially pharmaceutical dividend stocks that offer a bit of stability in rocky times.
Keep Reading →
May 1 - News
Would you hold a pharmaceutical product presentation in Hooters? That's just one of many alleged instances that the U.S.
Keep Reading →
May 1 - News
Big pharma is a controversial industry. Along with tobacco companies, they are some of the most vilified businesses in the world.
Keep Reading →
May 1 - News
In it's earnings call for last quarter, online retailer Amazon.com, Inc.
Keep Reading →
May 1 - News
Throughout the years, some of the best performing pharmaceutical industry stocks have had long histories of providing healthy dividends to their stockholders. Merck & Co., Inc...
Keep Reading →
April 30 - News
Patent expiration is one of the major issues faced by pharma companies, which increases the competition from generic medicines and eventually leads to downfall in their sales.
Keep Reading →
April 30 - News
One of the nice things about owning biotech companies is the large number of acquisitions in the sector.
Keep Reading →
April 30 - News
It’s not just about offering a better drug, but it’s also about launching it at the right time in the market.
Keep Reading →
April 28 - News
LONDON -- Back in January, I was looking to name (and shame) the five worst stocks on the FTSE 100 (INDEXFTSE:UKX), when my eyes alighted on GlaxoSmithKline plc (ADR) (GSK) (NYSE...
Keep Reading →
April 26 - News
Following in the footsteps of Abbott Laboratories (NYSE:ABT) spinning out its drug division into AbbVie Inc (NYSE:ABBV), and Pfizer spinning out its animal health division into...
Keep Reading →
April 26 - News
Northern Trust Corporation (NASDAQ:NTRS) FlexShares unit rolled out the International Quality Dividend Defensive Index Fund on Tuesday as part of a trio of new dividend ETFs with...
Keep Reading →
April 22 - Stock Analysis
LONDON -- It was a glum week for the FTSE 100 (INDEXFTSE:UKX), with the index of top U.K. stocks losing 98 points (1.5%) to end on 6,287.
Keep Reading →
April 21 - News
With the SPDR S&P Biotech Index up 37% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Keep Reading →
April 20 - News
Editor's Note: Related tickers: Theravance Inc (NASDAQ:THRX), GlaxoSmithKline plc (NYSE:GSK), Travelzoo Inc. (NASDAQ:TZOO), Arch Coal Inc (NYSE:ACI), Overstock.com, Inc.
Keep Reading →
April 18 - News
LONDON -- Next week is a busy week for news from FTSE 100 (INDEXFTSE:UKX) companies as first-quarter results time for those whose years end in December approaches -- and it ...
Keep Reading →
April 18 - News
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
Keep Reading →
April 18 - News
So much for the big correction.
Keep Reading →
April 17 - News
I hope to pinpoint the very best buying opportunities in today's uncertain market, as well as highlight those shares I feel you should hold...
Keep Reading →
April 15 - News
LONDON -- Shares of pharmaceutical giant GlaxoSmithKline plc (ADR) (LON:GSK) have performed well in the last month. While the FTSE 100 is down 1.5%, Glaxo is up 4.5%.
Keep Reading →
April 15 - News
Editor's Note: Related tickers: JPMorgan Chase & Co. (NYSE:JPM), Wells Fargo & Company (NYSE:WFC), Citigroup Inc.
Keep Reading →
April 15 - News
Earnings season is getting ready to rev into high gear, but earnings are unlikely to be the talk of the sector in the days to come, with three big Food and Drug Administration...
Keep Reading →
April 14 - News
The process of developing a drug from start to finish is incredibly arduous, usually involves around $1 billion in costs, and can take upwards of a decade to complete.
Keep Reading →
April 12 - News
LONDON -- After offering my pick of our telecom companies last week, today I'm turning my attention to the FTSE 100 Pharmaceuticals and Biotechnology sector.
Keep Reading →
April 12 - News
Looking for solid dividends? The health care sector has plenty of dividend stocks to choose from.
Keep Reading →
April 12 - News
LONDON -- The FTSE 100 has been off its highs for the past month, having set a new five-year record of 6,534 points on March 12.
Keep Reading →
April 11 - News
In this series I'm subjecting companies to scrutiny under five headings: prospects, performance, management, safety and valuation.
Keep Reading →
April 10 - News
The Dow Jones Industrial Average (Dow Jones Indices:.DJI) flashed a 60-point gain yesterday driven higher by the tech sector and its old dynamic duo, Microsoft Corporation (NASDAQ...
Keep Reading →
April 10 - News
Warren Buffett knows what he likes -- and he gets what he likes.
Keep Reading →
April 7 - News
April showers might bring May flowers, but the first week of the new month has already seen several health-care stocks hit full bloom.
Keep Reading →
April 7 - News
Before there was even a fancy term like "nicotine replacement therapy," the Swedish were using nicotine gum in the 1960s to help royal navy submariners manage their nicotine cravings...
Keep Reading →
April 7 - News
Abbott Laboratories (NYSE:ABT) has begun its new future swimmingly.
Keep Reading →
April 5 - News
There are many promising biotech companies out there to choose from. One such company, named Vical Incorporated (NASDAQ:VICL), is targeting a cancer known as Melanoma.
Keep Reading →
April 4 - News
As I noted five weeks ago, cancer statistics are both staggering and disappointing.
Keep Reading →
April 2 - News
LONDON -- I have recently been evaluating the investment cases for a multitude of FTSE 100 companies.
Keep Reading →
April 2 - News
I haven't ever heard him say it directly, but it's pretty clear that Warren Buffett has no interest in buying biotech companies.
Keep Reading →
March 31 - Hedge Funds
